Oneness Biotech Statistics
Total Valuation
Oneness Biotech has a market cap or net worth of EUR 929.97 million. The enterprise value is 760.12 million.
Market Cap | 929.97M |
Enterprise Value | 760.12M |
Important Dates
The last earnings date was Friday, March 7, 2025.
Earnings Date | Mar 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 308.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 2.84 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -22.14 |
EV / Sales | 231.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -65.26 |
Financial Position
The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.03.
Current Ratio | 39.87 |
Quick Ratio | 38.90 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | -1.03 |
Interest Coverage | -113.02 |
Financial Efficiency
Return on equity (ROE) is -8.45% and return on invested capital (ROIC) is -4.83%.
Return on Equity (ROE) | -8.45% |
Return on Assets (ROA) | -4.68% |
Return on Invested Capital (ROIC) | -4.83% |
Return on Capital Employed (ROCE) | -8.06% |
Revenue Per Employee | 80,810 |
Profits Per Employee | -798,427 |
Employee Count | 43 |
Asset Turnover | 0.01 |
Inventory Turnover | 0.46 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.56% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -59.56% |
50-Day Moving Average | 11.71 |
200-Day Moving Average | 18.69 |
Relative Strength Index (RSI) | 40.37 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oneness Biotech had revenue of EUR 3.47 million and -34.33 million in losses. Loss per share was -0.07.
Revenue | 3.47M |
Gross Profit | 1.86M |
Operating Income | -32.00M |
Pretax Income | -33.88M |
Net Income | -34.33M |
EBITDA | -20.07M |
EBIT | -32.00M |
Loss Per Share | -0.07 |
Balance Sheet
The company has 206.82 million in cash and 11.97 million in debt, giving a net cash position of 194.85 million.
Cash & Cash Equivalents | 206.82M |
Total Debt | 11.97M |
Net Cash | 194.85M |
Net Cash Per Share | n/a |
Equity (Book Value) | 377.16M |
Book Value Per Share | 0.76 |
Working Capital | 209.51M |
Cash Flow
In the last 12 months, operating cash flow was -10.18 million and capital expenditures -1.46 million, giving a free cash flow of -11.65 million.
Operating Cash Flow | -10.18M |
Capital Expenditures | -1.46M |
Free Cash Flow | -11.65M |
FCF Per Share | n/a |
Margins
Gross Margin | 53.45% |
Operating Margin | -920.96% |
Pretax Margin | -974.96% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Oneness Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.97% |
Shareholder Yield | -0.97% |
Earnings Yield | -3.69% |
FCF Yield | -1.25% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Oneness Biotech has an Altman Z-Score of 48.44.
Altman Z-Score | 48.44 |
Piotroski F-Score | n/a |